This inventor holds 3 USPTO granted patents. Top assignee: Human Genome Sciences, Inc.. Active years: 2001-2005.
Company Filing History:
Years Active: 2001-2005
Title: Thomas Spitznagel: Innovator in Keratinocyte Growth Factor-2 Formulations
Introduction
Thomas Spitznagel is a notable inventor based in Vienna, VA (US). He has made significant contributions to the field of biotechnology, particularly in the development of formulations for Keratinocyte Growth Factor-2 (KGF-2). With a total of 3 patents to his name, Spitznagel's work has the potential to impact therapeutic applications, especially in wound healing.
Latest Patents
One of Spitznagel's latest patents focuses on liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and its derivatives. This invention is directed towards the formulation of KGF-2 for therapeutic use, specifically to promote or accelerate wound healing. The innovative approach taken in these formulations showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Thomas Spitznagel has worked with prominent companies in the biotechnology sector, including Human Genome Sciences, Inc. and Human Genone Sciences, Inc. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in the field.
Collaborations
Some of his notable coworkers include Reiner L Gentz and Arvind Chopra. Their collaborative efforts have likely played a role in the successful development of his patented innovations.
Conclusion
Thomas Spitznagel's contributions to the field of biotechnology, particularly through his patents on Keratinocyte Growth Factor-2 formulations, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving therapeutic practices in wound healing.